CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Ontario Cannabis Store

The Ontario Cannabis Retail Corporation, operating as Ontario Cannabis Store is a Crown corporation that manages a legal monopoly over online retail of recreational cannabis to consumers and wholesale distribution to privately operated brick and mortar retailers throughout the province of Ontario, Canada.

Nationwide Wheelchair

Nationwide Wheelchair is a Melbourne, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MacPractice

MacPractice is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scimega Research Inc

Scimega Research Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Regenstrief Institute

Regenstrief Institute, Inc., an international leader in electronic medical records and health care data integration, is a medical research and development organization focused on improving quality of care, efficiency of health care delivery, and enhancing patient outcomes.